Physician profile
Mark J Dannenbaum
NPI 1275700924
$2,511.97
in general payments reported to CMS, 2019-2025
10 companies · $726 in 2025
The $726 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $111 · 2021: $267 · 2022: $134 · 2023: $260 · 2024: $626 · 2025: $726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $949.92 | 2021-2025 | Stealthstation S8 Platform, Strata |
| Stryker Corporation | $453.70 | 2019-2025 | Broadway 8, Trevo |
| Route 92 Medical, INC. | $271.26 | 2025 | |
| Depuy Synthes Sales INC. | $205.25 | 2024-2025 | Emboguard, Embotrap, Trufill |
| Zimmer Biomet Holdings, INC. | $144.42 | 2024 | Rosa |
| Imperative Care, INC | $130.77 | 2022-2024 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm |
| Medtronic USA, INC. | $126.94 | 2019-2020 | |
| Penumbra, INC. | $106.34 | 2019-2020 | |
| Balt USA, LLC | $90.36 | 2021-2025 | Optima Coil System |
| Microvention, INC. | $33.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dannenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.